Last Updated : April 23, 2025
Details
| Call for patient/clinician input open | 30-Jan-25 |
|---|---|
| Call for patient/clinician input closed | 24-Mar-25 |
| Submission received | 10-Mar-25 |
| Submission accepted | 25-Mar-25 |
| Review initiated | 26-Mar-25 |
| Draft CADTH review report(s) provided to sponsor for comment | 11-Jun-25 |
| Deadline for sponsors comments | 20-Jun-25 |
| CDA-AMC review report(s) and responses to comments provided to sponsor | 31-Jul-25 |
| Expert committee meeting (initial) | 13-Aug-25 |
| Draft recommendation issued to sponsor | August 25, 2025 To August 27, 2025 |
| Draft recommendation posted for stakeholder feedback | 04-Sep-25 |
| End of feedback period | 18-Sep-25 |
Details
| Call for patient/clinician input open | 13-Feb-25 |
|---|---|
| Call for patient/clinician input closed | 07-Apr-25 |
| Submission received | 27-Mar-25 |
| Submission accepted | 10-Apr-25 |
| Review initiated | 11-Apr-25 |
| Draft CADTH review report(s) provided to sponsor for comment | 07-Jul-25 |
| Deadline for sponsors comments | 16-Jul-25 |
| CDA-AMC review report(s) and responses to comments provided to sponsor | 28-Aug-25 |
| Expert committee meeting (initial) | 10-Sep-25 |
| Draft recommendation issued to sponsor | September 22, 2025 To September 24, 2025 |
| Draft recommendation posted for stakeholder feedback | 02-Oct-25 |
| End of feedback period | 17-Oct-25 |
Last Updated : April 23, 2025
Details
Review Type: Panel
Provisional Funding Algorithm |
|
|---|---|
| Scoping Document Posted for Feedback : | 13-Feb-2025 |
| Feedback Deadline : | 28-Feb-2025 |
Last Updated : February 13, 2025
Details
| Call for patient/clinician input open | February 11, 2025 |
|---|---|
| Call for patient/clinician input closed | April 07, 2025 |
| Submission received | March 26, 2025 |
| Submission accepted | April 09, 2025 |
| Review initiated | April 10, 2025 |
| Draft CADTH review report(s) provided to sponsor for comment | June 26, 2025 |
| Deadline for sponsors comments | July 08, 2025 |
| CDA-AMC review report(s) and responses to comments provided to sponsor | July 31, 2025 |
| Expert committee meeting (initial) | August 13, 2025 |
| Draft recommendation issued to sponsor | August 25, 2025 To August 27, 2025 |
| Draft recommendation posted for stakeholder feedback | September 04, 2025 |
| End of feedback period | September 18, 2025 |
Last Updated : April 21, 2025
Details
| Call for patient/clinician input open | 11-Feb-25 |
|---|---|
| Call for patient/clinician input closed | 07-Apr-25 |
| Submission received | 26-Mar-25 |
| Submission accepted | 09-Apr-25 |
| Review initiated | 10-Apr-25 |
| Draft CADTH review report(s) provided to sponsor for comment | 26-Jun-25 |
| Deadline for sponsors comments | 08-Jul-25 |
| CDA-AMC review report(s) and responses to comments provided to sponsor | 31-Jul-25 |
| Expert committee meeting (initial) | 13-Aug-25 |
| Draft recommendation issued to sponsor | August 25, 2025 To August 27, 2025 |
| Draft recommendation posted for stakeholder feedback | 04-Sep-25 |
| End of feedback period | 18-Sep-25 |
Last Updated : April 22, 2025
Details
| Call for patient/clinician input open | 10-Feb-25 |
|---|---|
| Call for patient/clinician input closed | 07-Apr-25 |
| Submission received | 25-Mar-25 |
| Submission accepted | 08-Apr-25 |
| Review initiated | 09-Apr-25 |
| Draft CADTH review report(s) provided to sponsor for comment | 25-Jun-25 |
| Deadline for sponsors comments | 07-Jul-25 |
| CDA-AMC review report(s) and responses to comments provided to sponsor | 31-Jul-25 |
| Expert committee meeting (initial) | 13-Aug-25 |
| Draft recommendation issued to sponsor | August 25, 2025 To August 27, 2025 |
| Draft recommendation posted for stakeholder feedback | 04-Sep-25 |
| End of feedback period | 18-Sep-25 |
Last Updated : April 23, 2025